Shandong Ruifeng Chemical Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Shandong Ruifeng Chemical's earnings have been declining at an average annual rate of -4.8%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 9.8% per year. Shandong Ruifeng Chemical's return on equity is 4.8%, and it has net margins of 2.9%.
Información clave
-4.8%
Tasa de crecimiento de los beneficios
-5.9%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.1% |
| Tasa de crecimiento de los ingresos | 9.8% |
| Rentabilidad financiera | 4.8% |
| Margen neto | 2.9% |
| Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
We Think That There Are More Issues For Shandong Ruifeng Chemical (SZSE:300243) Than Just Sluggish Earnings
Nov 01
We Think That There Are Some Issues For Shandong Ruifeng Chemical (SZSE:300243) Beyond Its Promising Earnings
Apr 26Recent updates
We Think That There Are More Issues For Shandong Ruifeng Chemical (SZSE:300243) Than Just Sluggish Earnings
Nov 01Optimistic Investors Push Shandong Ruifeng Chemical Co., Ltd. (SZSE:300243) Shares Up 41% But Growth Is Lacking
Oct 08Shandong Ruifeng Chemical (SZSE:300243) Will Be Hoping To Turn Its Returns On Capital Around
Sep 30Shandong Ruifeng Chemical Co., Ltd.'s (SZSE:300243) 34% Share Price Plunge Could Signal Some Risk
Jun 07Shandong Ruifeng Chemical (SZSE:300243) May Have Issues Allocating Its Capital
May 24We Think That There Are Some Issues For Shandong Ruifeng Chemical (SZSE:300243) Beyond Its Promising Earnings
Apr 26Optimistic Investors Push Shandong Ruifeng Chemical Co., Ltd. (SZSE:300243) Shares Up 48% But Growth Is Lacking
Apr 23Shandong Ruifeng Chemical Co., Ltd.'s (SZSE:300243) Shares Bounce 27% But Its Business Still Trails The Market
Mar 09Desglose de ingresos y gastos
Cómo gana y gasta dinero Shandong Ruifeng Chemical. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 1,929 | 56 | 183 | 14 |
| 30 Jun 24 | 1,918 | 65 | 187 | 11 |
| 31 Mar 24 | 1,853 | 77 | 189 | 15 |
| 31 Dec 23 | 1,776 | 85 | 187 | 15 |
| 30 Sep 23 | 1,790 | 68 | 191 | 11 |
| 30 Jun 23 | 1,719 | 48 | 197 | 11 |
| 31 Mar 23 | 1,741 | 47 | 203 | 7 |
| 01 Jan 23 | 1,832 | 61 | 210 | 6 |
| 30 Sep 22 | 1,856 | 64 | 218 | 5 |
| 30 Jun 22 | 1,887 | 76 | 208 | 5 |
| 31 Mar 22 | 1,962 | 93 | 198 | 2 |
| 31 Dec 21 | 1,858 | 93 | 183 | 4 |
| 30 Sep 21 | 1,788 | 112 | 138 | 4 |
| 30 Jun 21 | 1,700 | 127 | 143 | 3 |
| 31 Mar 21 | 1,495 | 105 | 154 | 6 |
| 31 Dec 20 | 1,302 | 85 | 154 | 4 |
| 30 Sep 20 | 1,185 | 77 | 187 | 5 |
| 30 Jun 20 | 1,127 | 62 | 176 | 5 |
| 31 Mar 20 | 1,098 | 64 | 162 | 6 |
| 31 Dec 19 | 1,213 | 75 | 176 | 5 |
| 30 Sep 19 | 1,261 | 67 | 181 | 8 |
| 30 Jun 19 | 1,311 | 80 | 187 | 6 |
| 31 Mar 19 | 1,473 | 94 | 200 | 4 |
| 31 Dec 18 | 1,445 | 90 | 183 | 4 |
| 30 Sep 18 | 1,369 | 89 | 157 | 1 |
| 30 Jun 18 | 1,300 | 70 | 139 | 2 |
| 31 Mar 18 | 1,138 | 44 | 119 | 1 |
| 31 Dec 17 | 1,096 | 31 | 117 | 1 |
| 30 Sep 17 | 1,055 | 16 | 141 | 1 |
| 30 Jun 17 | 1,001 | 17 | 145 | 0 |
| 31 Mar 17 | 935 | 10 | 145 | 0 |
| 31 Dec 16 | 874 | 15 | 145 | 0 |
| 30 Sep 16 | 822 | 35 | 134 | 0 |
| 30 Jun 16 | 815 | 36 | 128 | 0 |
| 31 Mar 16 | 811 | 48 | 123 | 0 |
| 31 Dec 15 | 805 | 47 | 121 | 0 |
| 30 Sep 15 | 811 | 40 | 120 | 0 |
| 30 Jun 15 | 848 | 41 | 117 | 0 |
| 31 Mar 15 | 860 | 38 | 117 | 0 |
| 31 Dec 14 | 846 | 35 | 106 | 0 |
| 30 Sep 14 | 852 | 32 | 106 | 0 |
| 30 Jun 14 | 793 | 30 | 104 | 0 |
| 31 Mar 14 | 762 | 27 | 104 | 0 |
| 31 Dec 13 | 759 | 28 | 101 | 0 |
Ingresos de calidad: 300243 has a large one-off gain of CN¥14.4M impacting its last 12 months of financial results to 30th September, 2024.
Margen de beneficios creciente: 300243's current net profit margins (2.9%) are lower than last year (3.8%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 300243's earnings have declined by 4.8% per year over the past 5 years.
Acelerando crecimiento: 300243's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Beneficios vs. Industria: 300243 had negative earnings growth (-18.1%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rentabilidad financiera
Alta ROE: 300243's Return on Equity (4.8%) is considered low.